بدائل البحث:
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), we decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
lower decrease » larger decrease (توسيع البحث), linear decrease (توسيع البحث), we decrease (توسيع البحث)
teer decrease » greater decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
-
1141
-
1142
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
منشور في 2024الموضوعات: -
1143
-
1144
Details of the GWAS data in this study.
منشور في 2025"…The effect of anti-H. pylori IgG seropositivity on CHD may be related to a higher peak insulin response or lower total free cholesterol levels and a decrease in waist circumference and waist-to-hip ratio. …"
-
1145
The Laboratory Animal Flow Diagram.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1146
<sup>1</sup>H NMR spectra for kylo-0603.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1147
<sup>13</sup>C NMR spectra for Kylo-0603.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1148
The structures of T3 and Kylo-0603.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1149
Synthesis process of Kylo-0603.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1150
ESI-HRMS spectra for Kylo-0603.
منشور في 2025"…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …"
-
1151
-
1152
-
1153
-
1154
-
1155
-
1156
-
1157
-
1158
Summary of post-treatment disease course measures from MDMA-AT publications.
منشور في 2025الموضوعات: -
1159
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
منشور في 2025الموضوعات: -
1160